Australia & New Zealand

In Australia we market pharmaceutical products including a portfolio of branded dermatology products and a range of oral and specialty generics. We also manufacture poppy-derived opiate raw materials that are primarily used in the manufacture of analgesics. All products are manufactured to meet the stringent standards of the Australian Therapeutic Goods Administration.

Globally, our vertically integrated operations including manufacturing of Active Pharmaceutical Ingredients (APIs) and Finished Dosage formulations, together with robust R&D capabilities, enable us to maintain strict control over the quality and cost of our marketed products.

We provide high-quality, affordable medicines trusted by healthcare professionals and patients in over 100 countries of the world. Our global presence is supported by 43 manufacturing facilities across 6 continents. We have a multi-cultural workforce comprising more than 41,000 employees in over 50 nationalities.